FDA Approves FluMist for At-Home Use
The FDA has authorized the use of FluMist, a nasal spray vaccine, for self-administration at home. This new approval provides a convenient alternative to the traditional flu shot especially for individuals who have needle aversion or find it challenging to visit healthcare settings for immunization.